Amgen Reunites With Kyowa Kirin in $400 Million Atopic Dermatitis Deal
Felicia Rodriguez
June 2, 2021
Via: https://www.biospace.com/article/amgen-reunites-with-kyowa-kirin-to-develop-atopic-dermatitis-drug-in-400-million-deal/?s=69 Amgen reunited with longtime developmental partner Japan’s Kyowa Kirin to develop a Phase III-ready atopic dermatitis treatment. This morning, California-based Amgen announced it will make a $400 million upfront payment to Kyowa Kirin to partner on the development and potential commercialization of KHK4083, the company’s potential first-in-class